ISSN: 2161-1149 (Printed)
+44-20-4587-4809
Vivian Herrera
Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936-1080, USA
Anti-TNFα biologic treatment; DMARDs; Treatment patterns; Costs; Persistence; Switch; Treatment modification